BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33845141)

  • 1. LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis.
    Dong S; Ma M; Li M; Guo Y; Zuo X; Gu X; Zhang M; Shi Y
    Genomics; 2021 Jul; 113(4):1689-1704. PubMed ID: 33845141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells.
    Li X; Chu X; Wang H; Xiang L; Yue X
    Chem Biol Drug Des; 2024 Mar; 103(3):e14488. PubMed ID: 38472166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
    Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
    Zhang X; Wu N; Wang J; Li Z
    J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MEG3 acts as a suppressor in breast cancer by regulating miR-330/CNN1.
    Yi D; Wang Z; Yang H; Wang R; Shi X; Liu Z; Xu F; Lu Q; Chu X; Sang J
    Aging (Albany NY); 2024 Jan; 16(2):1318-1335. PubMed ID: 38240701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA maternally expressed gene regulates cigarette smoke extract induced lung inflammation and human bronchial epithelial apoptosis via miR-149-3p.
    Lei Z; Guo H; Zou S; Jiang J; Kui Y; Song J
    Exp Ther Med; 2021 Jan; 21(1):60. PubMed ID: 33365060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer.
    Chang J; Zhang Y; Ye X; Guo H; Lu K; Liu Q; Guo Y
    Bioengineered; 2021 Dec; 12(1):8709-8723. PubMed ID: 34711117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MEG3 promotes endoplasmic reticulum stress and suppresses proliferation and invasion of colorectal carcinoma cells through the MEG3/miR-103a-3p/PDHB ceRNA pathway.
    Wang G; Ye Q; Ning S; Yang Z; Chen Y; Zhang L; Huang Y; Xie F; Cheng X; Chi J; Lei Y; Guo R; Han J
    Neoplasma; 2021 Mar; 68(2):362-374. PubMed ID: 33118833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.
    Xing Y; Zheng X; Fu Y; Qi J; Li M; Ma M; Wang S; Li S; Zhu D
    Mol Ther; 2019 Dec; 27(12):2166-2181. PubMed ID: 31477557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
    Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
    Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
    Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
    Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
    J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
    Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
    Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.